GlassScriptPhysician profile
Brooklyn Elkan
NPI 1508479908
$612.00
in general payments reported to CMS, 2019-2025
11 companies · $51.68 in 2025
The $51.68 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.36 · 2023: $334 · 2024: $178 · 2025: $51.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.65 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $148.52 | 2023-2025 | Veozah |
| Medical Device Business Services, INC. | $129.54 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.34 | 2023-2025 | Mirena, Kyleena |
| Exeltis, USA INC. | $55.95 | 2022-2023 | Slynd |
| Mayne Pharma Commercial LLC | $52.31 | 2023 | |
| Biogen, INC. | $27.78 | 2024 | Zurzuvae |
| Ethicon US, LLC | $20.76 | 2024 | Enseal X1 |
| Boston Scientific Corporation | $20.64 | 2024 | |
| Abbvie INC. | $19.13 | 2022 | |
| Hologic Sales and Service, LLC | $15.99 | 2022 | |
| Dexcom, INC. | $14.04 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooklyn Elkan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.